ABT-046 is a potent and selective oral DGAT-1 inhibitor used in metabolic disease research. It has been employed in studies investigating obesity and type 2 diabetes, demonstrating utility in both in vitro enzymatic assays and in vivo models of metabolic dysfunction.
Molekulargewicht:
350.41
Reinheit:
98.13% (May vary between batches)
CAS Nummer:
[1031336-60-3]
Formel:
C20H22N4O2
Target-Kategorie:
Transferase,Acyltransferase
Anwendungsbeschreibung:
Solubility: DMSO:50 mg/mL (142.69 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten